In partnership with

Transmission from Ricardo

Hey Neurohacker,

We’ve been doing this for almost a year—next issue marks one full year. I just want to say thank you for showing up week after week. It genuinely means a lot.

You might’ve noticed I’ve been making a lot of changes around The NeuroCircuit, and I’ve officially launched the website for HΛCK THΞ NΞVRΘN—more to come there soon.

This week’s Signal introduces a new format. I’m experimenting a bit, so let me know what you think—whether you prefer this style, the usual paragraph format, or something else entirely.

Lastly, if you haven’t already, join the new Discord and take a moment to check out our sponsors. Even just giving them a look helps support the newsletter and grow the community.

Table of Contents

🧠 Weekly Signal

Neurotechnology News | March 21–27, 2026

Let's cut through the noise.

This week, a Parkinson’s study challenged a core assumption in neuromodulation.
At the same time, gene therapy and BCI deployment kept accelerating, while neural data regulation fractured further.

Bottom line:
Neurotech may need to get better at damping unstable signals—not just amplifying them.

⚡ Signal of the Week

A peer-reviewed study (eNeuro, March 23) directly challenged a widely held belief:

That impaired movement is mainly caused by too little motor drive.

Researchers at Emory University found the opposite pattern.

  • The cortex wasn’t underactive → it was over-engaged

  • Higher cortical activity → worse balance recovery

  • Muscles co-contracted, increasing stiffness instead of stability

Translation:
The system isn’t weak. It’s overcorrecting.

💡 Why this matters:
Most closed-loop systems assume:

More signal = better outcome

That assumption may be wrong.

👉 We may need inhibition-aware control systems, not just stronger stimulation.

🔬 SCIENCE & CLINICAL TRIALS

🟢 Parkinson’s balance model flips

Published: March 23, 2026
Read more Science Daily / eNeuro

Researchers decomposed muscle responses into:

  • Subcortical signals

  • Cortical latency responses

They found:

  • Elevated cortical responses even at low challenge levels

  • Higher cortical activity → poorer outcomes

  • Opposing muscles activating simultaneously (co-contraction)

💡 Big Picture:
Closed-loop neuromodulation needs to shift from:

➡️ Amplification logic
➡️ to stability + inhibition control

🟢 Meta advances TRIBE-V2 brain model

Published: March 26 2026
Read more ➡️ Meta AI Blog

Meta introduced TRIBE-V2, a predictive foundation model trained on brain activity data to model and forecast neural signals at scale.

The system is designed to:

  • Generalize across datasets

  • Learn reusable representations of brain dynamics

  • Move beyond task-specific decoding

This positions neural data as something that can be:

  • Pretrained on

  • Transferred across tasks

  • Scaled like other AI modalities

💡 Big Picture:
The stack is shifting from:

➡️ Task-specific decoders
➡️ to foundation models for brain data

🟢 Encoded advances ETX101 pivotal trial

Published: March 25, 2026
Read more NeurologyLive / NIH / BioSpace

Encoded Therapeutics aligned with the FDA on a pivotal trial design for ETX101:

  • Targets SCN1A-positive Dravet syndrome

  • Uses AAV9 gene regulation

  • 30 patients, randomized, double-blind, sham-controlled

  • 52-week trial across US, UK, Australia

💡 Big Picture:
We’re moving from:

➡️ Gene therapy as concept
➡️ to precision gene regulation as a clinical product

💼 INDUSTRY & STARTUPS

🟢 China’s Beinao-1 pushes semi-invasive BCI

Published: March 23, 2026
Read more Technology.org / Chinese Academy of Sciences

NeuCyber NeuroTech has:

  • Implanted 5 ALS patients

  • Matched Neuralink patient count

  • Used an epidural (semi-invasive) approach

Tradeoff:

  • Lower signal fidelity

  • Lower surgical risk

  • 🚀 Faster scalability (50–100 patients projected)

💡 Big Picture:
The race is no longer just:

➡️ Who has the best decoder
➡️ but which invasiveness tradeoff wins

🟢 Synchron wins data science recognition

Published: March 27, 2026
Read more FastCompany

Synchron was named one of the most innovative data science companies of 2026.

No new clinical data—but that’s the point.

They’re positioning as:

A brain-data platform company—not just a device company.

💡 Big Picture:
The market is shifting toward:

➡️ Data + models > hardware alone

🏛️ POLICY & ETHICS

Thank you for tuning in! there are no Policy & Ethics signals for the week.

🔍 Open Question This Week

If neurodegeneration often looks like runaway excitation

Are we building systems that only know how to accelerate?

Where are the systems designed to:

  • Brake

  • Stabilize

  • Dampen noise

Because that might be the real bottleneck.

🤝 This week’s partnership

The Future of Tech. One Daily News Briefing.

AI is moving faster than any other technology cycle in history. New models. New tools. New claims. New noise.

Most people feel like they’re behind. But the people that don’t, aren’t smarter. They’re just better informed.

Forward Future is a daily news briefing for people who want clarity, not hype. In one concise newsletter each day, you’ll get the most important AI and tech developments, learn why they matter, and what they signal about what’s coming next.

We cover real product launches, model updates, policy shifts, and industry moves shaping how AI actually gets built, adopted, and regulated. Written for operators, builders, leaders, and anyone who wants to sound sharp when AI comes up in the meeting.

It takes about five minutes to read, but the edge lasts all day.

Reply

Avatar

or to participate

Keep Reading